• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Lurasidone-induced Parkinsonism and Hyperprolactinemia.
Indian J Psychol Med. 2019 Mar-Apr;41(2):192-194. doi: 10.4103/IJPSYM.IJPSYM_274_18.
2
Lurasidone: The 2016 update on the pharmacology, efficacy and safety profile.鲁拉西酮：2016年药理学、疗效及安全性概况更新
Pharmacol Rep. 2016 Aug;68(4):748-55. doi: 10.1016/j.pharep.2016.04.002. Epub 2016 Apr 22.
3
Lurasidone Induced Thrombocytopenia: Is it a Signal of Drug Induced Myelosuppression?鲁拉西酮所致血小板减少症：它是药物性骨髓抑制的信号吗？
Indian J Psychol Med. 2018 Mar-Apr;40(2):191-192. doi: 10.4103/IJPSYM.IJPSYM_374_17.
4
Lurasidone-induced anemia: Is there a need for hematological monitoring?鲁拉西酮致贫血：是否需要进行血液学监测？
Indian J Pharmacol. 2019 Jul-Aug;51(4):276-278. doi: 10.4103/ijp.IJP_434_18.
5
Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?鲁拉西酮用于成人精神分裂症的急性治疗：治疗所需人数、伤害所需人数以及获益或伤害可能性分别是多少？
Clin Schizophr Relat Psychoses. 2012 Jul;6(2):76-85. doi: 10.3371/CSRP.6.2.5.
6
[Short-term efficacy and safety of lurasidone in the treatment of schizophrenia].鲁拉西酮治疗精神分裂症的短期疗效与安全性
Encephale. 2014 Dec;40(6):507-17. doi: 10.1016/j.encep.2014.10.009.
7
Management of bipolar I depression: clinical utility of lurasidone.双相 I 型抑郁症的管理：鲁拉西酮的临床应用
Ther Clin Risk Manag. 2015 Jan 8;11:75-81. doi: 10.2147/TCRM.S57695. eCollection 2015.
8
Short-term efficacy and tolerability of lurasidone in the treatment of acute schizophrenia: A meta-analysis of randomized controlled trials.短期疗效和耐受性的鲁拉西酮治疗急性精神分裂症:一项随机对照试验的荟萃分析。
J Psychiatr Res. 2018 Aug;103:244-251. doi: 10.1016/j.jpsychires.2018.06.005. Epub 2018 Jun 5.
9
Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.鲁拉西酮治疗精神分裂症：这一新批准的第二代抗精神病药物的疗效和安全性概况综述。
Int J Clin Pract. 2011 Feb;65(2):189-210. doi: 10.1111/j.1742-1241.2010.02587.x. Epub 2010 Dec 3.
10
Lurasidone in schizophrenia: new information about dosage and place in therapy.氨磺必利治疗精神分裂症：关于剂量和治疗地位的新信息。
Adv Ther. 2012 Oct;29(10):815-25. doi: 10.1007/s12325-012-0052-6. Epub 2012 Sep 20.

引用本文的文献

1
Risk of Drug-induced Movement Disorders with Newer Antipsychotic Agents.新型抗精神病药物致药物诱导运动障碍的风险。
Tremor Other Hyperkinet Mov (N Y). 2022 Jun 8;12:19. doi: 10.5334/tohm.695. eCollection 2022.
2
Can Isolated Head Tremors Be an Extrapyramidal Symptom Associated with Lurasidone?-A Case Series.孤立性头部震颤会是与鲁拉西酮相关的锥体外系症状吗？——病例系列
Indian J Psychol Med. 2021 Nov;43(6):546-548. doi: 10.1177/02537176211010505. Epub 2021 Jun 2.

本文引用的文献

1
Lurasidone-Induced Rabbit Syndrome: A Case Report.鲁拉西酮所致兔综合征：一例报告
J Clin Psychiatry. 2017 May;78(5):e553. doi: 10.4088/JCP.16cr11157.
2
Lurasidone: The 2016 update on the pharmacology, efficacy and safety profile.鲁拉西酮：2016年药理学、疗效及安全性概况更新
Pharmacol Rep. 2016 Aug;68(4):748-55. doi: 10.1016/j.pharep.2016.04.002. Epub 2016 Apr 22.
3
A Case of Emergent Restless Legs Syndrome With Lurasidone Therapy.
J Clin Psychopharmacol. 2016 Jun;36(3):293-4. doi: 10.1097/JCP.0000000000000496.
4
The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.新型和新批准的抗精神病药对血清催乳素水平的影响：全面综述。
CNS Drugs. 2014 May;28(5):421-53. doi: 10.1007/s40263-014-0157-3.
5
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.15 种抗精神分裂症药物的疗效和耐受性比较：一项多治疗荟萃分析。
Lancet. 2013 Sep 14;382(9896):951-62. doi: 10.1016/S0140-6736(13)60733-3. Epub 2013 Jun 27.
6
Drug-induced parkinsonism.药物性帕金森病。
Expert Opin Drug Saf. 2013 Jul;12(4):487-96. doi: 10.1517/14740338.2013.787065. Epub 2013 Mar 31.
7
Drug-induced parkinsonism.药物性帕金森病。
J Clin Neurol. 2012 Mar;8(1):15-21. doi: 10.3988/jcn.2012.8.1.15. Epub 2012 Mar 31.
8
Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity.新型抗精神病药物鲁拉西酮的药理学特性，其对 5-羟色胺 7（5-HT7）受体和 5-羟色胺 1A（5-HT1A）受体具有强大的活性。
J Pharmacol Exp Ther. 2010 Jul;334(1):171-81. doi: 10.1124/jpet.110.167346. Epub 2010 Apr 19.
9
Pharmacological causes of hyperprolactinemia.高泌乳素血症的药理学病因。
Ther Clin Risk Manag. 2007 Oct;3(5):929-51.
10
Manual for the Extrapyramidal Symptom Rating Scale (ESRS).锥体外系症状评定量表（ESRS）手册。
Schizophr Res. 2005 Jul 15;76(2-3):247-65. doi: 10.1016/j.schres.2005.02.013. Epub 2005 Apr 18.

Lurasidone-induced Parkinsonism and Hyperprolactinemia.

作者信息

Suthar Navratan, Aneja Jitender

机构信息

Department of Psychiatry, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.

出版信息

Indian J Psychol Med. 2019 Mar-Apr;41(2):192-194. doi: 10.4103/IJPSYM.IJPSYM_274_18.

DOI:10.4103/IJPSYM.IJPSYM_274_18
PMID:30983673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6436398/
Abstract
摘要